Andrea Pfeifer Selected Research

Nootropic Agents (Nootropics)

1/2014	Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014.
1/2014	Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.
1/2014	Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
1/2013	Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
1/2013	Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs.
1/2012	Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Pfeifer Research Topics

Disease

24	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2007
4	Tauopathies 01/2021 - 01/2013
3	Amyloid Plaque 12/2016 - 01/2012
3	Schizophrenia (Dementia Praecox) 01/2013 - 01/2012
3	Stroke (Strokes) 01/2013 - 01/2012
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2013 - 01/2012
2	Down Syndrome (Down's Syndrome) 01/2022 - 01/2016
2	Edema (Dropsy) 01/2022 - 07/2012
2	Inflammation (Inflammations) 01/2022 - 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Pick Disease of the Brain (Pick's Disease) 01/2021
1	Corticobasal Degeneration 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Trisomy (Trisomies) 01/2016
1	Hemorrhage 01/2016
1	Amyloidosis 01/2014
1	Cognitive Dysfunction 01/2013
1	Disease Progression 01/2012
1	Proteostasis Deficiencies 04/2011

Drug/Important Bio-Agent (IBA)

13	Amyloid (Amyloid Fibrils)IBA 01/2022 - 06/2007
11	Peptides (Polypeptides)IBA 01/2017 - 04/2011
6	VaccinesIBA 01/2022 - 04/2011
6	Nootropic Agents (Nootropics)IBA 01/2014 - 01/2012
4	Liposomes (Liposome)IBA 01/2022 - 04/2011
3	tau Proteins (tau Protein)IBA 11/2018 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
2	Amyloid beta-PeptidesIBA 09/2019 - 01/2014
2	LigandsIBA 01/2012 - 01/2012
1	PI-2620IBA 01/2021
1	CalpainIBA 11/2018
1	7-azaindole dimerIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	indoleIBA 01/2017
1	EpitopesIBA 01/2017
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2014
1	Apolipoprotein E4IBA 07/2012
1	D1 peptideIBA 04/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	AntibodiesIBA 06/2007

Therapy/Procedure

4	Therapeutics 01/2014 - 03/2011
1	Immunotherapy 01/2013